A new study by the Scripps Research Translational Institute suggests Fitbits could be used to detect the flu. By tracking resting heart rate and activity levels, researchers said Fitbits could improve detection of outbreaks at the state level.
Gilead is in-licensing investigational molecules for influenza, rhinovirus and herpes. Novartis will receive an upfront payment and an additional $291 million in milestones.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
EHRs can be a nuisance. But new research shows data from electronic health records can be a useful tool for population health surveillance.
The system's estimates of national and regional flu activity had error rates 2- to 3-fold lower than earlier predictive models. It also correctly estimated the timing and magnitude of the national flu peak week.
Prosetta Biosciences says it'll use the proceeds mostly for more antiviral R&D. It has an assembly line approach to producing a series of compounds that alter the assembly of the viral capsid.
VaxInnate, a New Jersey startup, has raised more equity - on top of $53 million in government contracts - to develop a seasonal and pandemic flu vaccine.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Testing for the flu just got a lot faster.
Wisconsin startup FluGen is developing a flu vaccine that's meant to protect against mutated forms of the virus. It just raised a $12 million Series A to do so.
Vasculotide helps prevent against influenza by targeting fluid leakage in lungs instead of attacking the sometimes deadly virus directly.
New Jersey’s VaxInnate is developing inoculations to ward off seasonal and pandemic flu, dengue fever and Clostridium difficile. The well-capitalized company has raised a recent round of $6 million, according to a regulatory filing. The company genetically fuses vaccine antigens to flagellin, a protein that forms the flagella of a bacterium that’s known for being highly […]
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Infectious diseases like dengue fever influenza of the seasonal and pandemic varieties are the top targets for Cambridge biotech Visterra, which has just raised a hefty Series B round – to the tune of $30 million – for its immunotherapies. The company plans to bring its influenza therapy into Phase 2 trial with the new cash […]
Fujifilm has made an offer to the World Health Organization to distribute a stockpile of anti-influenza meds that could treat up to 20,000 individuals with Ebola. A new New Yorker article outlines why – how digital imaging behemoth Fujifilm is playing what could be an important role in the treatment of Ebola. Five years ago, it […]
Mobile health company Kinsa continued its victory lap around the startup competition circuit at the Cleveland Clinic Medical Innovation Summit today, taking home top honors at the summit’s first ever new ventures healthcare challenge. Eleven startups from the StartUp Health Network, which co-presented the challenge with Cleveland Clinic, pitched to a panel of judges that […]
The new MedImmune vaccination is the big news for this year’s flu season – that and athena health stepping in while the CDC staff is furloughed. This new flu shot is supposed to protect against four strains instead of just one. MedImmune has to have a good sales pitch, in part because the vaccine is […]
Eric Chen isn’t your average 17-year-old. When the high school junior isn’t in school, he’s working with biologists at the University of California, San Diego, using their supercomputers and wet labs to conduct drug discovery research on potential new anti-viral medicines. This week, that work earned Chen the title of Google Science Fair winner. His […]